These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32083287)

  • 21. Clinic Factors Associated With Mailed Fecal Immunochemical Test (FIT) Completion: The Difference-Making Role of Support Staff.
    Davis MM; Schneider JL; Petrik AF; Miech EJ; Younger B; Escaron AL; Rivelli JS; Thompson JH; Nyongesa D; Coronado GD
    Ann Fam Med; 2022; 20(2):123-129. PubMed ID: 35346927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial.
    Brenner AT; Rhode J; Yang JY; Baker D; Drechsel R; Plescia M; Reuland DS; Wroth T; Wheeler SB
    Cancer; 2018 Aug; 124(16):3346-3354. PubMed ID: 30004577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and Cost-effectiveness of Mailed FIT in a Safety Net Clinic Population.
    Pignone M; Lanier B; Kluz N; Valencia V; Chang P; Olmstead T
    J Gen Intern Med; 2021 Nov; 36(11):3441-3447. PubMed ID: 33929646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders.
    Baldwin LM; Schneider JL; Schwartz M; Rivelli JS; Green BB; Petrik AF; Coronado GD
    BMC Health Serv Res; 2020 Feb; 20(1):132. PubMed ID: 32085767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Survey of Provider Attitudes, Beliefs, and Perceived Barriers Regarding a Centralized Direct-Mail Colorectal Cancer Screening Approach at Community Health Centers.
    Thompson JH; Schneider JL; Rivelli JS; Petrik AF; Vollmer WM; Fuoco MJ; Coronado GD
    J Prim Care Community Health; 2019; 10():2150132719890950. PubMed ID: 31779517
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
    Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
    JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.
    O'Connor EA; Vollmer WM; Petrik AF; Green BB; Coronado GD
    Trials; 2020 Jan; 21(1):91. PubMed ID: 31941527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees.
    Mojica CM; Gunn R; Pham R; Miech EJ; Romer A; Renfro S; Clark KD; Davis MM
    BMC Cancer; 2022 Jan; 22(1):106. PubMed ID: 35078444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States - How, what and when?
    Davis MM; Freeman M; Shannon J; Coronado GD; Stange KC; Guise JM; Wheeler SB; Buckley DI
    BMC Cancer; 2018 Jan; 18(1):40. PubMed ID: 29304835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.
    Baker DW; Brown T; Goldman SN; Liss DT; Kollar S; Balsley K; Lee JY; Buchanan DR
    Cancer Causes Control; 2015 Nov; 26(11):1685-90. PubMed ID: 26337733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial.
    Sequist TD; Zaslavsky AM; Marshall R; Fletcher RH; Ayanian JZ
    Arch Intern Med; 2009 Feb; 169(4):364-71. PubMed ID: 19237720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study.
    Coronado GD; Green BB; West II; Schwartz MR; Coury JK; Vollmer WM; Shapiro JA; Petrik AF; Baldwin LM
    Cancer; 2020 Feb; 126(3):540-548. PubMed ID: 31658375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase in the Colorectal Cancer Screening Rate by a Round-Mailed Fecal Immunochemical Testing Kit and Associated Factors in Underserved Regions of Korea: A Community-Based Intervention Study.
    Hong S; Shin HY; Lee B; Hwang NR; Hwang SH; Jun JK
    Gut Liver; 2020 May; 14(3):323-330. PubMed ID: 31530737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.
    Rat C; Pogu C; Le Donné D; Latour C; Bianco G; Nanin F; Cowppli-Bony A; Gaultier A; Nguyen JM
    JAMA; 2017 Sep; 318(9):816-824. PubMed ID: 28873160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced Notification Calls Prior to Mailed Fecal Immunochemical Test in Previously Screened Patients: a Randomized Controlled Trial.
    Lee B; Patel S; Rachocki C; Issaka R; Vittinghoff E; Shapiro JA; Ladabaum U; Somsouk M
    J Gen Intern Med; 2020 Oct; 35(10):2858-2864. PubMed ID: 32748345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving Fecal Immunochemical Test Return Rates: A Colorectal Cancer Screening Quality Improvement Project in a Multisite Federally Qualified Health Center.
    Zoellner JM; Porter KJ; Thatcher E; Allanson D; Brauns M
    Health Promot Pract; 2023 Jul; 24(4):740-754. PubMed ID: 35382617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in Reaching Medicaid and Medicare Enrollees in a Mailed Fecal Immunochemical Test Program.
    Green BB; West II; Baldwin LM; Schwartz MR; Coury J; Coronado GD
    J Community Health; 2020 Oct; 45(5):916-921. PubMed ID: 32219712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.
    Pham R; Cross S; Fernandez B; Corson K; Dillon K; Yackley C; Davis MM
    J Am Board Fam Med; 2017; 30(5):632-644. PubMed ID: 28923816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.